IPCA Laboratories

IPCA Laboratories Dividend

The Dividend of IPCA Laboratories (IPCALAB.NS) as of Nov 3, 2026 is 2.00 INR. In the previous year, Dividend was 4.00 INR — a change of -50.00% (lower).

Dividend

2.00INR

YoY

-50.00%

Dividend yield

0.10 %

Last updated:

How much dividend does IPCA Laboratories 2026 pay?

According to the latest status from November 2026, IPCA Laboratories paid a total of 2.00 INR per share in dividends within the last 12 months. With the current IPCA Laboratories price of 1,957.60 INR, this corresponds to a dividend yield of 0.10 %. A dividend is paid times per year.

IPCA Laboratories currently offers a dividend yield of about 0.10%. The payout ratio is around 12% of earnings. The dividend has grown at 5.3% per year over the past 19 years.

Historical IPCA Laboratories Dividends

A dividend is paid times per year. Last year, the payout months were and September.

Historical IPCA Laboratories Dividends
PaydateDividend
6.00INR
2.00INR
2.00INR
2.00INR
2.00INR
4.00INR
4.00INR
4.00INR
2.50INR
1.50INR
0.50INR
0.50INR
0.50INR
1.25INR
1.25INR
1.00INR
1.00INR
0.60INR
0.50INR
0.50INR
0.60INR
0.50INR
0.50INR
0.50INR
0.40INR
0.50INR
0.40INR
0.30INR
0.40INR
0.45INR
0.35INR
0.40INR
0.35INR
0.30INR
0.25INR
0.30INR
0.25INR
0.30INR
0.25INR
0.45INR
0.28INR
0.08INR
0.18INR
0.13INR
0.15INR
0.13INR
0.15INR
0.13INR
0.13INR
0.20INR
0.14INR
0.14INR

The IPCA Laboratories Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2022
4.00 INR
Jan 1, 2023
2.00 INR
Jan 1, 2024
4.00 INR
Jan 1, 2025
2.00 INR
Jan 1, 2026
2.00 INR
Jan 1, 2027 (e)
6.00 INR
Jan 1, 2028 (e)
14.40 INR
Jan 1, 2029 (e)
17.28 INR
The IPCA Laboratories Dividend history
YEARDividendYoY
est17.28INR+20.00%
est14.40INR+140.00%
est6.00INR+200.00%
2.00INR0.00%
2.00INR-50.00%
4.00INR+100.00%
2.00INR-50.00%
4.00INR0.00%
4.00INR-38.46%
6.50INR+333.33%
1.50INR+200.00%
0.50INR0.00%
0.50INR0.00%
0.50INR0.00%
0.50INR-60.00%
1.25INR-44.44%
2.25INR+7.14%
2.10INR+31.25%
1.60INR+14.29%
1.40INR+16.67%
1.20INR+41.18%
0.85INR+13.33%
0.75INR—

IPCA Laboratories dividend history and estimates

In 2025, IPCA Laboratories paid a dividend amounting to 2.00 INR. Dividend means that IPCA Laboratories distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Special dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2022
4.00 INR
0.00 INR
0.00 INR
Jan 1, 2023
2.00 INR
0.00 INR
0.00 INR
Jan 1, 2024 (e)
4.00 INR
0.00 INR
0.00 INR
Jan 1, 2025
2.00 INR
0.00 INR
0.00 INR
Jan 1, 2026 (e)
2.00 INR
2.00 INR
0.00 INR
Jan 1, 2027 (e)
6.00 INR
6.00 INR
0.00 INR
Jan 1, 2028 (e)
0.00 INR
14.40 INR
0.00 INR
Jan 1, 2029 (e)
0.00 INR
17.28 INR
0.00 INR

Is the IPCA Laboratories Dividend Safe?

IPCA Laboratories has been increasing the dividend for 0 years.

Over the past 10 years, IPCA Laboratories has increased it by an annual 14.87%.

Over a five-year period, the distribution dropped by -12.94%.

Analysts expect a Dividend Increase of 144.95% for the current fiscal year.

IPCA Laboratories dividend payout ratio

In 2025, IPCA Laboratories had a payout ratio of 6.88%. The payout ratio indicates the percentage of the company's profits that IPCA Laboratories distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2022
11.48 %
Jan 1, 2023
10.77 %
Jan 1, 2024
18.54 %
Jan 1, 2025
6.88 %
Jan 1, 2026
12.06 %
Jan 1, 2027 (e)
20.00 %
Jan 1, 2028 (e)
20.51 %
Jan 1, 2029 (e)
21.30 %

Dividend Details

Understanding IPCA Laboratories's Dividend Distributions

IPCA Laboratories’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining IPCA Laboratories's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

IPCA Laboratories's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in IPCA Laboratories’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

IPCA Laboratories Stock analysis

What does IPCA Laboratories do? Ipca Laboratories Ltd. generates revenue through the manufacturing and marketing of over 350 pharmaceutical formulations and approximately 80 active pharmaceutical ingredients (APIs), including Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts, and Propranolol. The company sells its branded products such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, and Venpower in more than 100 countries globally. Its subsidiaries, Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd, and Tonira Exports Limited, support the distribution and sales of these products across international markets. The company's primary customers are healthcare providers, hospitals, and pharmacies in over 100 countries, purchasing both generic APIs and branded formulations. Manufacturing units in India produce APIs and formulations, with the firm's subsidiaries facilitating global market access. The therapeutic segments covered by its products include cardiovascular, antimalarial, and gastrointestinal treatments, among others, driven by the demand for cost-effective pharmaceutical solutions. IPCA Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IPCA Laboratories stock

Over the past 12 months, IPCA Laboratories paid a dividend of 2.00 INR . This corresponds to a dividend yield of about 0.10 %. For the coming 12 months, IPCA Laboratories is expected to pay a dividend of 12.00 INR.

The current dividend yield of IPCA Laboratories is 0.10 %.

IPCA Laboratories pays a dividend, distributed in the months of August, November.

IPCA Laboratories paid dividends every year for the past 9 years.

For the upcoming 12 months, dividends amounting to 12.00 INR are expected. This corresponds to a dividend yield of 0.62 %.

IPCA Laboratories is assigned to the 'Health' sector.

In the year 2025, IPCA Laboratories distributed 2 INR as dividends.

The dividends of IPCA Laboratories are distributed in INR.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

All Key Metrics — IPCA Laboratories